Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Imitrex(Sumatriptan Succinate)

Medicare prescription drug cost, prescriptions and prescribers, 2024

$5.1M

Medicare cost, 2024

Medicare drug plans spent $5.1 million on Imitrex (sumatriptan succinate) in 2024, for 3,210 prescriptions and refills filled by 803 patients. California accounts for the most spending ($919,246, 18% of the total).

Medicare cost, 2024

$5.1M

+0.0% from 2023

Prescriptions

3,210

$1,599.87 per claim

Patients

803

903 prescribers

Total spending

-

All plans

Questions and answers

How much does Medicare spend on Imitrex?

Medicare prescription drug plans paid $5.1M for Imitrex in 2024, for 3,210 prescriptions and refills to 803 patients (up 0.0% from 2023). The average cost per claim was $1,599.87.

Which state spends the most on Imitrex?

California had the highest Medicare cost for Imitrex in 2024: $919K for 540 claims, followed by New York ($579K).

Who prescribes Imitrex the most?

Norman M Gordon, neurology in East Providence, RI, had the highest Medicare cost for Imitrex in 2024: 13 claims costing $136K.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Imitrex, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Norman M Gordon East Providence, RINeurology13Under 11$136K
Brian L Nguyen Sun City, CAInternal Medicine19Under 11$97K
Robert Richard Reston, VANeurology11Under 11$87K
Kelly L Scott Ogdensburg, NYInternal Medicine15Under 11$79K
Marcela S Espinosa Huntington Beach, CAInternal Medicine12Under 11$66K
William H Burstein Philadelphia, PAInternal Medicine13Under 11$56K
Edward G Hill Jr. Winston Salem, NCNeurology30Under 11$53K
Stephen Hryniewicki Long Beach, CAInternal Medicine19Under 11$51K
Annika M Brown Lebanon, NHFamily Practice11Under 11$50K
Tyler C Dixon Clinton, UTFamily Practice25Under 11$50K
Christopher M McMackin Washington, DCInternal Medicine13Under 11$47K
James P Bergstrom Fridley, MNInternal Medicine19Under 11$37K
Ann C Morrill White Marsh, MDInternal Medicine12Under 11$33K
David S Haden Virginia Beach, VAInternal Medicine12Under 11$30K
Christopher P O'Carroll Newport Beach, CANeurology12Under 11$27K
Wheeler T Maxwell Philadelphia, PAFamily Practice20Under 11$27K
Orli R Etingin New York, NYInternal Medicine17Under 11$26K
Leonid Segal Horseheads, NYNeurology19Under 11$26K
Kate E Kennedy Bellevue, WANurse Practitioner13Under 11$25K
David D Van Slooten Westwood, NJNeurology18Under 11$22K
Francis B Ponce Shrewsbury, NJNeurology11Under 11$22K
Xiomara Munoz Bothell, WAFamily Practice12Under 11$21K
Ilkcan Cokgor Greenbrae, CANeurology13Under 11$16K
Eugene F Boss Springfield, MAInternal Medicine19Under 11$16K
Peter A Luongo Paramus, NJInternal Medicine11Under 11$15K

Prescriber data by year

YearPrescribersClaimsPatientsCost
20221,0003,966851$5.3M
20238933,643771$5.1M
20249033,210803$5.1M

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube